Orange Book product · Generic (ANDA)
HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE
At a glance
Jul 02, 1984
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 02, 1984
42 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE
Strength
50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 088587
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCHLOROTHIAZIDE
- 2025INZIRQOBrand (NDA)
NDA 219141 · NOVITIUM PHARMA
- 1996MICROZIDEBrand (NDA)
NDA 020504 · TEVA BRANDED PHARM
- —ESIDRIXBrand (NDA)
NDA 011793 · NOVARTIS
- 2024HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 083177 · IVAX SUB TEVA PHARMS
- 2023HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 085182 · HERITAGE
- 2019HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 203561 · SCIEGEN PHARMS
- 2014HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090651 · SUN PHARM INDS INC
- 2012HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 202556 · ACCORD HLTHCARE
- 2012HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 091662 · CHARTWELL MOLECULAR
- 2010HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 200645 · ALEMBIC PHARMS LTD
- 2010HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090510 · UNICHEM
- 2009HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 079237 · IPCA LABS LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
